Products

AG000JLR

122852-69-1 | Alosetron (hydrochloride)

AG000JLR

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

CAS Number	122852-69-1
Catalog Number	AG000JLR(AGN-PC-0PGRMV)
Chemical Name	Alosetron (hydrochloride)
IUPAC Name	5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride
InChI	InChI=1S/C17H18N4O.ClH/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2;/h3-6,10H,7-9H2,1-2H3,(H,18,19);1H
InChI Key	FNYQZOVOVDSGJH-UHFFFAOYSA-N
MDL Number	MFCD03453647
Molecular Formula	C17H19ClN4O
Molecular Weight	330.8120
SMILES	O=C1N(CC2=C(C)N=CN2)CCC(N3C)=C1C4=C3C=CC=C4.[H]Cl
UNII	2F5R1A46YW
Synonyms	2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride, alosetron, alosetron hydrochloride, alosetron monohydrochloride, GR 68755, GR68755, Lotronex, ALOSETRON HYDROCHLORIDE, 122852-69-1, Alosetron HCl, Lotronex, GR 68755c, Alosetron (Hydrochloride), alosetron monohydrochloride, GR 68755, UNII-2F5R1A46YW, Alosetron hydrochloride [USAN], HSDB 7055, GR 68755X, Alosetron Hydrochloride(1:X), 2F5R1A46YW, GR68755, GR-68755C, 132414-02-9, 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one hydrochloride, C17H19ClN4O, DSSTox_CID_24208, DSSTox_RID_80120, DSSTox_GSID_44208, 2,3,4,5-Tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one monohydrochloride, Alosetron [INN:BAN], Q-200613, Alosetron hydrochloride (USAN), MLS001401464, CHEBI:53783, 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride, 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-, monohydrochloride, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one;hydrochloride, CAS-122852-69-1, NCGC00167528-01, 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-, SMR000469211, Lotrpnex (TN), 5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one hydrochloride, 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one hydrochloride, alosetron-hydrochloride, PubChem21073, SCHEMBL806, AC1L1TV5, AC1Q3EM0, C17H18N4O.HCl, REGID_for_CID_60758, CHEMBL1200885, DTXSID8044208, Alosetron (Hydrochloride(1:X)), CTK8F0331, FNYQZOVOVDSGJH-UHFFFAOYSA-N, BCP08834, EBD27746, KS-00000Z0H, Tox21_112525, AC-022, HY-70050C, MFCD03453647, s4694, AKOS015889472, AKOS015961658, Tox21_112525_1, API0001419, AT-2898, CCG-100910, CS-0642, NC00160, VA10239, NCGC00167528-02, Alosetron hydrochloride, >=98% (HPLC), AN-16216, CC-23908, CPD000469211, GR-68755, Q640, SAM001246782, AB0017713, LS-172541, LS-172542, RT-011248, FT-0631109, A14989, D02829, W-5305, 852A691, A804978, I01-2212, 1H-Pyrido[4,3-b]indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-, hydrochloride (1:1), 2,3,4,5-tetrahydro-5-methyl-2-((5-methylimidazol-4-yl)methyl)-1H-pyridol(4,3-b)indol-1-one monohydrochloride, 2,3,4,5-Tetrahydro-5-methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-1H-pyrido[4,3-b]indol-1-one Hydrochloride, 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1-H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride, 2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one Hydrochloride / 5-Methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one Hydrochloride, 2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one, monohydrochloride, 5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydro-2H-pyrido[4,3-b]indol-1(5H)-one hydrochloride, alosetron, Phoslactomycin D, Alosetron-d3 Hydrochloride, ALOSETRONHYDROCHLORIDE, C17H18N4O.ClH, C18H19N3O.HCl, Alosetron hydrochloride (1:X), C17-H18-N4-O.Cl-H, CID60758, CS-O-11589, A3159, A3197, C090840, 122852-42-0, 1189919-71-8, 2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one,

Complexity	442
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	330.125g/mol
Formal Charge	0
Heavy Atom Count	23
Hydrogen Bond Acceptor Count	2
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	330.816g/mol
Monoisotopic Mass	330.125g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	53.9A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard statements	H301-H319-H411
Precuationary statements	P273-P301+P310-P305+P351+P338
Siginal words	dangerous

Product Recommendations

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited